A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)

Clinical trial NCT07264595 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07264595
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pediatric Growth Hormone Deficiency

Start date: 2025-12-01
Primary completion: 2030-11-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.